XML 29 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests in Consolidated Affiliates
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 $ 1,692,940 $ 0 $ 872,228 $ 707,378 $ 711 $ 13,417 $ (711) $ 99,917
Beginning balance (in shares) at Dec. 31, 2017     128,970,776          
Beginning balance at Dec. 31, 2017 1,692,940 0 $ 872,228 707,378 711 13,417 (711) 99,917
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 1,654,550 $ 0 $ 884,263 672,371 $ 711 239 $ (711) 97,677
Net income (loss) 117,330     102,216       15,114
Net income attributable to noncontrolling interest in the Operating Partnership 0              
Dividends (137,934)     (137,934)        
Issuance of shares under incentive stock plans, (in shares)     599,422          
Issuance of shares under incentive stock plans 8,591   $ 8,591          
Stock-based compensation 6,428   $ 6,428          
Repurchase of common shares, (in shares)     (81,523)          
Repurchase of common shares (2,984)   $ (2,984)          
Actuarial change and amortization of pension and postretirement plan liabilities (919)         (919)    
Foreign currency translation adjustment (22,759)         (17,329)   (5,430)
Cash flow hedges 5,029         5,781   (752)
Distributions to noncontrolling interests in consolidated affiliates (11,172)             (11,172)
Ending balance (in shares) at Dec. 31, 2018     129,488,675          
Ending balance at Dec. 31, 2018 1,654,550   $ 884,263 672,371   239   97,677
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 1,654,550   884,263 672,371   239   97,677
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 1,654,550   $ 888,177 583,006   (31,202)   97,661
Net income (loss) 67,678     59,105       8,573
Net income attributable to noncontrolling interest in the Operating Partnership 0              
Dividends (140,040)     (140,040)        
Issuance of shares under incentive stock plans, (in shares)     298,003          
Issuance of shares under incentive stock plans 1,260   $ 1,260          
Stock-based compensation 6,904   $ 6,904          
Repurchase of common shares, (in shares)     (455,609)          
Repurchase of common shares (12,680)   $ (4,250) (8,430)        
Actuarial change and amortization of pension and postretirement plan liabilities (1,350)         (1,350)    
Foreign currency translation adjustment 963         784   179
Cash flow hedges (30,482)         (30,875)   393
Distributions to noncontrolling interests in consolidated affiliates (9,161)             (9,161)
Ending balance (in shares) at Dec. 31, 2019     129,331,069          
Ending balance at Dec. 31, 2019 1,537,642   $ 888,177 583,006   (31,202)   97,661
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 1,537,642   888,177 583,006   (31,202)   97,661
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 1,862,645   $ 1,101,675 446,267   (31,202)   388,588
Issuances of shares associated with the merger with Pope Resources (in shares)     7,181,071          
Issuances of shares associated with the merger with Pope Resources 172,418   $ 172,418          
Net income (loss) 29,784     37,612       (7,828)
Net income attributable to noncontrolling interest in the Operating Partnership (528)     (528)        
Dividends (146,278)     (146,278)        
Issuance of shares under the “at-the-market” equity offering, net of commissions and offering costs of $799 (in shares)     1,103,012          
Issuance of shares under the “at-the-market” equity offering, net of commissions and offering costs of $799 32,574   $ 32,574          
Issuance of shares under incentive stock plans, (in shares)     266,036          
Issuance of shares under incentive stock plans 1,589   $ 1,589          
Stock-based compensation 8,026   $ 8,026          
Repurchase of common shares, (in shares)     (219,619)          
Repurchase of common shares (4,757)   $ (1,605) (3,152)        
Acquisition of noncontrolling interests in consolidated affiliates 333,366             333,366
Adjustment of noncontrolling interest in the Operating Partnership (24,393)     (24,393)        
Conversion of units into common shares (in shares)     17,253          
Conversion of units into common shares 496   $ 496          
Actuarial change and amortization of pension and postretirement plan liabilities (925)         (925)    
Foreign currency translation adjustment 28,272         22,928   5,344
Cash flow hedges (61,055)         (62,146)   1,091
Allocation of other comprehensive income to noncontrolling interests in the Operating Partnership (2,540)         (2,540)    
Distributions to noncontrolling interests in consolidated affiliates (12,643)             (12,643)
Noncontrolling interests in consolidated affiliates redemption of shares (28,403)             (28,403)
Ending balance (in shares) at Dec. 31, 2020     137,678,822          
Ending balance at Dec. 31, 2020 1,862,645   $ 1,101,675 446,267   (73,885)   388,588
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment due to adoption of ASU No. 2018-02 $ 1,862,645   $ 1,101,675 $ 446,267   $ (73,885)   $ 388,588